INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 424m ago
HOUSE PTR24m ago
SEC 13F24m ago
ROBINHOOD CHAIN24m ago
Public company

BIO-TECHNE Corp

TECHCIK 0000842023

EDGAR filingsOpen in network
Price$72.78
1 year+21.4%
Disclosed transactions3
Buys / sells0 / 3
Max Insider Score20
Connections with evidence3

TECH · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
16
April McClain DelaneyDDependent child
TECHBIO-TECHNE Corp
Sale
SELL$1,001 – $15KApr 8, 2026

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2836 · Biological Products, (No Diagnostic Substances) · Nov 4, 2026
  • ← Lobbied forevidence
    SQUIRE PATTON BOGGSLDA Q2Y 2026 second quarter · issues not listed · Aug 26, 2026
  • ← Disclosed trade inevidence
    April McClain DelaneySale disclosed 2026-03-10 · Mar 10, 2026
May 6, 2026
traded Apr 8, 2026
+28d
HOUSE PTR

Evidence

16
April McClain DelaneyDDependent child
TECHBIO-TECHNE Corp
Partial sale
SELL$1,001 – $15KMar 26, 2026Apr 6, 2026
traded Mar 26, 2026
+11dHOUSE PTR

Evidence

20
April McClain DelaneyDDependent child
TECHBIO-TECHNE Corp
Partial sale
SELL$1,001 – $15KFeb 24, 2026Mar 10, 2026
traded Feb 24, 2026
+14dHOUSE PTR

Evidence

Lobbying

$0 reported · de-duplicated
2026 Q2 $0 via firms2026 Q1 $0 via firms
  • SQUIRE PATTON BOGGS—2026 Q2 · posted Aug 26, 2026 ·
  • SQUIRE PATTON BOGGS—2026 Q1 · posted Aug 26, 2026 · Agriculture

Connected PAC contributions

FEC · direct to members

No contributions from a PAC connected to this company.